# NKX2-3

## Overview
NKX2-3 is a gene that encodes the NK2 homeobox 3 protein, a transcription factor belonging to the NK-2 class of homeobox genes. This protein is characterized by its homeobox domain, which facilitates specific DNA binding, playing a crucial role in regulating gene expression during developmental processes (Vojkovics2018Nkx23—A). NK2 homeobox 3 is involved in various biological functions, including the development and maintenance of lymphoid tissues, intestinal homeostasis, and tooth cusp formation. It is also implicated in the regulation of immune responses and inflammation (Han2018The; Pabst2000NKX2.3). Clinically, mutations and genetic variations in NKX2-3 are associated with inflammatory bowel diseases and certain lymphomas, highlighting its significance in both normal physiology and disease states (John2011NKX23; Robles2016Homeobox).

## Structure
The NKX2-3 protein is a transcription factor characterized by its homeobox domain, a helix-turn-helix DNA-binding motif typical of the NK-2 class homeobox genes. This domain allows NKX2-3 to bind DNA with specificity, particularly to CAAG core sequences, which is crucial for its role in regulating gene expression during development (Vojkovics2018Nkx23—A). The primary structure of NKX2-3 consists of a sequence of amino acids that form the basis for its secondary and tertiary structures. The secondary structure includes alpha helices, which are common in homeobox proteins and contribute to the protein's ability to interact with DNA. The tertiary structure involves the folding of these helices into a three-dimensional shape, facilitating precise DNA binding and interaction with other molecular partners.

While specific details about the quaternary structure of NKX2-3 are not provided, the protein's function as a transcription factor suggests it may interact with other proteins to form complexes that regulate gene expression. Post-translational modifications and splice variants may also influence the activity and stability of NKX2-3, although specific modifications are not detailed in the available context. The NKX2-3 gene is highly intolerant to loss-of-function variations, indicating its critical role in development (Kerkhofs2019Mutations).

## Function
The NKX2-3 gene encodes a transcription factor that plays a significant role in the development and function of lymphoid tissues and the intestinal system. In healthy human cells, NKX2-3 is active in the nucleus, where it binds to DNA and regulates the transcription of target genes involved in inflammation and immune response. It is crucial for the expression of the mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in endothelial cells, which is essential for lymphocyte homing to mucosal tissues, thereby maintaining intestinal homeostasis and influencing inflammation (Vojkovics2018Nkx23—A).

NKX2-3 is also involved in tooth development, particularly in the formation of tooth cusps. It regulates the expression of the cell cycle regulator p21 in dental epithelial cells, influencing cell proliferation and fate determination in the enamel knot, a critical structure for cusp formation. NKX2-3's role in regulating p21 expression is mediated through its binding to the promoter region of the Cdkn1a gene, which encodes p21, thereby directly influencing its expression (Han2018The).

In the spleen, NKX2-3 is essential for maintaining the correct positioning of lymphoid and stromal cells, which is critical for the proper function of secondary lymphoid organs. Its absence leads to structural and functional defects in the spleen and mucosa-associated lymphoid tissues (Pabst2000NKX2.3).

## Clinical Significance
Mutations and alterations in the NKX2-3 gene are associated with several diseases, particularly inflammatory bowel diseases (IBD) such as Crohn's disease (CD) and ulcerative colitis (UC). Genetic variants like SNP rs11190140 have been linked to IBD, with the T allele being over-transmitted in affected populations. This SNP affects transcription factor binding, potentially altering NKX2-3 expression and contributing to IBD pathogenesis (John2011NKX23). NKX2-3 is also implicated in the development of marginal-zone lymphomas, including splenic marginal zone lymphoma (SMZL) and mucosa-associated lymphoid tissue (MALT) lymphomas. The gene induces constitutive B-cell receptor signaling, which is a common feature in these lymphomas, leading to changes in B-cell dynamics and promoting lymphomagenesis (Robles2016Homeobox).

In hematopoietic malignancies, NKX2-3 overexpression due to gene translocation can lead to splenic MZ lymphoma and MALT lymphomas. It is also associated with B-cell acute lymphoblastic leukemia (B-ALL) and T-cell acute lymphoblastic leukemia (T-ALL), where its expression influences lymphocyte differentiation and maturation (Vojkovics2018Nkx23—A). Additionally, a nonsense mutation in NKX2-3 has been linked to idiopathic intestinal varicosis, a developmental disorder affecting the spleen and intestinal vasculature (Kerkhofs2019Mutations).

## Interactions
NKX2-3 is a transcription factor that participates in various interactions with proteins and nucleic acids, influencing gene expression and cellular processes. It is known to bind to specific DNA sequences in the promoter regions of target genes, affecting transcriptional regulation. In the context of inflammatory bowel disease (IBD), the NKX2-3 gene variant rs11190140 has been shown to alter the binding of transcription factors such as NFAT1, NF-κB, and ETS-1 to the NKX2-3 promoter region. This interaction is influenced by the methylation status of the rs11190140 site, which can modulate transcription factor binding and potentially affect NKX2-3 gene transcription (John2011NKX23).

In tooth development, NKX2-3 interacts with the ectodysplasin-A (EDA) signaling pathway, regulating the expression of the cell cycle regulator p21 by binding to its promoter. This interaction influences cell proliferation in the enamel knot, a critical signaling center for cusp formation (Han2018The).

In acute myeloid leukemia (AML), NKX2-3 is involved in the regulation of megakaryocytic-erythroid cell differentiation. It activates the transcription factor FLI1, which is crucial for the differentiation of megakaryocytes and erythrocytes, highlighting its role in hematopoietic lineage differentiation (Nagel2021NKL).


## References


[1. (Han2018The) Xue Han, Keigo Yoshizaki, Kanako Miyazaki, Chieko Arai, Keita Funada, Tomomi Yuta, Tian Tian, Yuta Chiba, Kan Saito, Tsutomu Iwamoto, Aya Yamada, Ichiro Takahashi, and Satoshi Fukumoto. The transcription factor nkx2-3 mediates p21 expression and ectodysplasin-a signaling in the enamel knot for cusp formation in tooth development. Journal of Biological Chemistry, 293(38):14572–14584, September 2018. URL: http://dx.doi.org/10.1074/jbc.ra118.003373, doi:10.1074/jbc.ra118.003373. This article has 28 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra118.003373)

[2. (Vojkovics2018Nkx23—A) Dóra Vojkovics, Zoltán Kellermayer, Béla Kajtár, Giovanna Roncador, Áron Vincze, and Péter Balogh. Nkx2-3—a slippery slope from development through inflammation toward hematopoietic malignancies. Biomarker Insights, January 2018. URL: http://dx.doi.org/10.1177/1177271918757480, doi:10.1177/1177271918757480. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1177/1177271918757480)

[3. (Pabst2000NKX2.3) O. Pabst. Nkx2.3 is required for madcam-1 expression and homing of lymphocytes in spleen and mucosa-associated lymphoid tissue. The EMBO Journal, 19(9):2015–2023, May 2000. URL: http://dx.doi.org/10.1093/emboj/19.9.2015, doi:10.1093/emboj/19.9.2015. This article has 81 citations.](https://doi.org/10.1093/emboj/19.9.2015)

[4. (John2011NKX23) Gerrit John, John P. Hegarty, Wei Yu, Arthur Berg, Danielle M. Pastor, Ashley A. Kelly, Yunhua Wang, Lisa S. Poritz, Stefan Schreiber, Walter A. Koltun, and Zhenwu Lin. Nkx2-3 variant rs11190140 is associated with ibd and alters binding of nfat. Molecular Genetics and Metabolism, 104(1–2):174–179, September 2011. URL: http://dx.doi.org/10.1016/j.ymgme.2011.06.023, doi:10.1016/j.ymgme.2011.06.023. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ymgme.2011.06.023)

[5. (Kerkhofs2019Mutations) Chantal Kerkhofs, Servi J. C. Stevens, Saul N. Faust, William Rae, Anthony P. Williams, Peter Wurm, Rune Østern, Paul Fockens, Christiane Würfel, Martin Laass, Freddy Kokke, Alexander P. A. Stegmann, and Han G. Brunner. Mutations inrpsaandnkx2‐3link development of the spleen and intestinal vasculature. Human Mutation, 41(1):196–202, September 2019. URL: http://dx.doi.org/10.1002/humu.23909, doi:10.1002/humu.23909. This article has 9 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.23909)

[6. (Robles2016Homeobox) Eloy F. Robles, Maria Mena-Varas, Laura Barrio, Sara V. Merino-Cortes, Péter Balogh, Ming-Qing Du, Takashi Akasaka, Anton Parker, Sergio Roa, Carlos Panizo, Idoia Martin-Guerrero, Reiner Siebert, Victor Segura, Xabier Agirre, Laura Macri-Pellizeri, Beatriz Aldaz, Amaia Vilas-Zornoza, Shaowei Zhang, Sarah Moody, Maria Jose Calasanz, Thomas Tousseyn, Cyril Broccardo, Pierre Brousset, Elena Campos-Sanchez, Cesar Cobaleda, Isidro Sanchez-Garcia, Jose Luis Fernandez-Luna, Ricardo Garcia-Muñoz, Esther Pena, Beatriz Bellosillo, Antonio Salar, Maria Joao Baptista, Jesús Maria Hernandez-Rivas, Marcos Gonzalez, Maria Jose Terol, Joan Climent, Antonio Ferrandez, Xavier Sagaert, Ari M. Melnick, Felipe Prosper, David G. Oscier, Yolanda R. Carrasco, Martin J. S. Dyer, and Jose A. Martinez-Climent. Homeobox nkx2-3 promotes marginal-zone lymphomagenesis by activating b-cell receptor signalling and shaping lymphocyte dynamics. Nature Communications, June 2016. URL: http://dx.doi.org/10.1038/ncomms11889, doi:10.1038/ncomms11889. This article has 40 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms11889)

[7. (Nagel2021NKL) Stefan Nagel, Claudia Pommerenke, Corinna Meyer, and Roderick A. F. MacLeod. Nkl homeobox genes nkx2-3 and nkx2-4 deregulate megakaryocytic-erythroid cell differentiation in aml. International Journal of Molecular Sciences, 22(21):11434, October 2021. URL: http://dx.doi.org/10.3390/ijms222111434, doi:10.3390/ijms222111434. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms222111434)